Prevagen Maker, Consumers Want OK for Global False Ad Settlement

June 25, 2020, 2:19 PM

Quincy Bioscience LLC and consumers alleging it duped them about the effectiveness of its Prevagen memory supplement asked a federal court in Florida to approve a nationwide class settlement that provides label changes and partial refunds to potentially 3 million people.

Plaintiffs say there’s no basis for the company’s claims that Prevagen can help memory or cognition. Prevagen’s active ingredient, a dietary protein first discovered in glowing jellyfish, is digested and transformed into amino acids before it can measurably affect the brain, they allege.

Quincy Bioscience agreed to an uncapped settlement that gives buyers back 30% of the manufacturer’s suggested ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.